Literature DB >> 23541742

Low dopamine D5 receptor density in hippocampus in an animal model of attention-deficit/hyperactivity disorder (ADHD).

T Medin1, J E Rinholm, S G Owe, T Sagvolden, A Gjedde, J Storm-Mathisen, L H Bergersen.   

Abstract

A state of low dopaminergic activity has been implicated in attention-deficit/hyperactivity disorder (ADHD). The clinical symptoms of ADHD include inattention, impulsivity and hyperactivity, as well as impaired learning; dopaminergic modulation of the functions in the hippocampus is important to both learning and memory. To determine dopamine receptor (DR) density in a well-established animal model for ADHD, we quantified the dopamine D5 receptors in the hippocampus in the spontaneously hypertensive rat. We used immunofluorescence microscopy and immunogold electron microscopy to quantify the dopamine D5 receptor density on CA1 pyramidal cell somas and dendrites and dendritic spines in the stratum radiatum and stratum oriens. The density of the dopamine D5 receptors was significantly lower in the cytoplasm of pyramidal cell somas in the spontaneously hypertensive rat compared to the control, indicating a reduced reservoir for insertion of receptors into the plasma membrane. DRs are important for long-term potentiation and long-term depression, hence the deficit may contribute to the learning difficulties in individuals with the diagnosis of ADHD.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541742     DOI: 10.1016/j.neuroscience.2013.03.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

Review 1.  Imaging functional and structural brain connectomics in attention-deficit/hyperactivity disorder.

Authors:  Miao Cao; Ni Shu; Qingjiu Cao; Yufeng Wang; Yong He
Journal:  Mol Neurobiol       Date:  2014-04-05       Impact factor: 5.590

2.  Sansoninto, a traditional herbal medicine, ameliorates behavioral abnormalities and down-regulation of early growth response-1 expression in mice exposed to social isolation stress.

Authors:  Hironori Fujiwara; Ryohei Tsushima; Ryo Okada; Suresh Awale; Ryota Araki; Takeshi Yabe; Kinzo Matsumoto
Journal:  J Tradit Complement Med       Date:  2017-04-12

3.  Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.

Authors:  Hironori Fujiwara; Yaoyu Han; Ken Ebihara; Suresh Awale; Ryota Araki; Takeshi Yabe; Kinzo Matsumoto
Journal:  BMC Complement Altern Med       Date:  2017-04-04       Impact factor: 3.659

4.  Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum Chemokines.

Authors:  Ahmet Özaslan; Esra Güney; Özlem Gülbahar; Dicle Büyüktaskin; Burak Arslan
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

Review 5.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

6.  Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.

Authors:  Frank Faltraco; Denise Palm; Adriana Uzoni; Lena Borchert; Frederick Simon; Oliver Tucha; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2021-07-18       Impact factor: 3.575

7.  Shared and Distinct Topologically Structural Connectivity Patterns in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Authors:  Lu Qian; Yun Li; Yao Wang; Yue Wang; Xin Cheng; Chunyan Li; Xiwen Cui; Gongkai Jiao; Xiaoyan Ke
Journal:  Front Neurosci       Date:  2021-06-11       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.